2025 Satellite Symposia Schedule

Tuesday, February 4, 2025, 06:45-07:45
Fighting Fire: Inflammation and Chronic Pain in Fabry Disease
Sponsored by Takeda Pharmaceuticals International AG
This satellite is open only to registered attendees from outside the United States. International participants only.

Tuesday, February 4, 2025, 06:45-07:45
Imaging Innovation: Harnessing Technology to Transform Patient Care
Sponsored by Sanofi

Tuesday, February 4, 2025, 12:15-13:15
Unraveling NPC and GMx: From disease insights to pivotal study designs
Sponsored by Azafaros B.V.

Tuesday, February 4, 2025, 12:15-13:15
MLD Gene Therapy: Early Detection and Diagnosis, Clinical Experience, and Cost Effectiveness of Newborn Screening in MLD 
Sponsored by Orchard Therapeutics

Tuesday, February 4, 2025, 17:45-18:45
A case-based approach to navigating treatment switch in late-onset Pompe disease (LOPD)
Sponsored by Amicus Therapeutics

Tuesday, February 4, 2025, 17:45-18:45
Enzyme Replacement Therapy: Time to Act in Lysosomal Diseases
Sponsored by Chiesi Global Rare Diseases

Wednesday, February 5, 2025, 06:45-07:45
Lessons Learned from Advanced Therapies for Genetic Diseases: A Conversation
Sponsored by Astellas Gene Therapies, Inc

Wednesday, February 5, 2025, 06:45-07:45
Voices in unison: insights into the unmet needs in MPS II from patient community and physician perspectives
Sponsored by Denali Therapeutics

Wednesday, February 5, 2025, 12:15-13:15
Gaucher Disease: Challenges in Assessment and Management of Bone Disease
CE Satellite Symposium
Accredited provider: Postgraduate Institute for Medicine (PIM)
Jointly Provided by PIM and Saterdalen & Associates LLC
Supported by an independent educational grant from Takeda Pharmaceuticals U.S.A. Inc.

Wednesday, February 5, 2025, 12:15-13:15
Red light, green light…What about the yellow light? Exploring the Complexities of Treatment Tolerability in Fabry Disease
Sponsored by Chiesi Global Rare Diseases

Wednesday, February 5, 2025, 17:45-18:45M
LOPD: Elevating Care Through Patient Insights
CE Satellite Symposium
Accredited provider: Amedco
Jointly Provided by Amedco and EPG Health
Supported by an independent educational grant from Amicus Therapeutics

Wednesday, February 5, 2025, 17:45-18:45
30 years of Rare Disease Registries and Beyond: Bridging Science and Patient Experience to Optimize Care
Sponsored by Sanofi

Thursday, February 6, 2025, 06:45-07:45
Transforming Clinical Outcomes with Early Treatment of Lysosomal Disorders
CE Satellite Symposium
Accredited provider: AffinityCE
Jointly Provided by: AffinityCE and Lysosomal & Rare Disorders Research & Treatment Center, Inc (LDRTC)

Thursday, February 6, 2025, 06:45-07:45
Novel Long-Term Real-World Data in Fabry Disease: Outcome Analysis in a New Therapeutic Environment
Sponsored by Sanofi

Thursday, February 6, 2025, 12:15-13:15
Advancing Collaboration in Patient Equity and Innovation in Fabry Disease Care
Sponsored by Amicus Therapeutics

Thursday, February 6, 2025, 12:15-13:15
The Great Debate: Lysosomal disease progression: When to treat?
Sponsored by Sanofi

---

Exhibitor Prospectus, including Satellite Symposia opportunities will be available July 1, 2024.

Titles and content for Satellite Symposia will be posted as information becomes available.

These Satellite Symposia are not part of the official WORLDSymposium™ program, and WORLDSymposium does not approve or endorse any commercial products or services discussed during the Satellite Symposia or offered for sale by any corporate supporter of the Satellite Symposia. These symposia may or may not offer CE credits; these sessions are not approved for CE through WORLDSymposium.

Eligibility: Registration for WORLDSymposium 2025 and an official name badge are required to attend satellite symposia.